US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

205.96

-4.5700-2.17%

Post-market: 205.960.00000.00%19:30 EDT

Volume:1.55M

Turnover:321.61M

Market Cap:10.45B

PE:32.63

High:211.73

Open:210.09

Low:205.84

Close:210.53

52wk High:217.12

52wk Low:144.65

Shares:50.75M

Float Shares:50.75M

Volume Ratio:1.07

T/O Rate:3.05%

Dividend:0.34

Dividend Rate:0.16%

EPS(TTM):6.31

EPS(LYR):35.34

ROE:24.54%

ROA:0.10%

PB:1.28

PE(LYR):5.83

Loading ...

Overview Company News Filings

Sanofi CEO Takes First Step Toward Addressing Long-Term Outlook

Sanofi to Get Pipeline Boost from Expanded Regeneron Alliance

Sanofi, Regeneron Expand Tie-up with $8 Billion Drug-Development Deal, Settle Legal Dispute

Regeneron, Sanofi Expand Antibody Alliance with USD 1 Billion Upfront Payment

Sanofi, Regeneron Expand Antibody Alliance in Long-Acting Immunology Programs for USD 1 Billion Upfront

Sanofi - Companies to Equally Share Development and Commercialization Costs, as Well as Any Future Profits

THOMSON REUTERS

Sanofi - and Regeneron Settle Prior Collaboration-Related Litigation

THOMSON REUTERS

Sanofi - Regeneron May Include Sanofi's Lunsekimig Therapy After Phase 3 Studies

THOMSON REUTERS

Sanofi - Regeneron to Receive $1 Bln Upfront with Potential for up to an Additional $7 Bln in Future Milestone Payments

THOMSON REUTERS

Arovella Nears First Patient Dosing in Pivotal ALA-101 Cell Therapy Trial

The Next Frontier for Obesity Drugs Isn't How Much Weight You Lose, but What Kind

Regeneron Drug Halves Muscle Loss in Combination with Novo's Semaglutide in Trial

Gilead Sciences Inc. Stock Underperforms Wednesday When Compared to Competitors

Moderna Inc. Stock Sheds 5.4%, Underperforms Peers

Regeneron Links 2026 CEO, CSO PSU Awards to FDA Filings, Approvals and New-Product Revenue Targets Through 2035

Gilead put volume heavy and directionally bearish

Exchange-Traded Funds Higher, US Equities Mixed After Midday

MT Newswires Live

Sector Update: Healthcare

MT Newswires Live

Regeneron’s ALN-F1202 Safety Trial Marks a Quiet but Important Pipeline Milestone

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/IBB/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"iShares Biotechnology ETF","latestPrice":205.96,"timestamp":1790884800000,"preClose":210.53,"halted":0,"volume":1546879,"hourTrading":{"tag":"盘后","latestPrice":205.96,"preClose":205.96,"latestTime":"19:30 EDT","volume":7162,"amount":1475288.405,"timestamp":1790897406045,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.021707120125397772,"floatShares":50750000,"shares":50750000,"eps":6.311863,"marketStatus":"Not Yet Opened","change":-4.57,"latestTime":"10-01 16:00:00 EDT","open":210.085,"high":211.73,"low":205.84,"amount":321610885.85687,"amplitude":0.027977,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790928000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":210.53,"sharesOutstanding":49450000,"nav":210.463323,"aum":11112463454.4,"dividendRate":0.001637,"bidAskSpread":0.00039,"preHourTrading":{"tag":"盘前","latestPrice":210,"preClose":210.53,"latestTime":"09:27 EDT","volume":198,"amount":41672.93328,"timestamp":1790861278000,"change":-0.53,"changeRate":-0.002517,"amplitude":0.010126},"postHourTrading":{"tag":"盘后","latestPrice":205.96,"preClose":205.96,"latestTime":"19:30 EDT","volume":7162,"amount":1475288.405,"timestamp":1790897406045,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.06677,"impliedVol":0.2407,"impliedVolPercentile":0.5976},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50750000,"roa":"0.10%","roe":"24.54%","lyrEps":35.344796,"volumeRatio":1.06677,"shares":50750000,"dividePrice":0.3371,"high":211.73,"amplitude":0.027977,"preClose":210.53,"low":205.84,"week52Low":144.65,"pbRate":"1.28","psRate":"251.48","week52High":217.12,"institutionHeld":0,"latestPrice":205.96,"eps":6.311863,"divideRate":0.001637,"volume":1546879,"delay":0,"ttmEps":6.311863,"open":210.085,"prevYearClose":168.77,"prevWeekClose":209.77,"prevMonthClose":210.53,"prevQuarterClose":210.53,"fiveDayClose":209.25,"twentyDayClose":213.8,"sixtyDayClose":196.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"IBB","amount":0.011194,"announcedDate":"2026-09-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-18"},{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"},{"executeDate":"2018-06-26","recordDate":"2018-06-27","paymentDate":"2018-07-02","value":0.15606,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672758407","title":"Sanofi CEO Takes First Step Toward Addressing Long-Term Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2672758407","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672758407?lang=en_us&edition=fundamental","pubTime":"2026-10-01 16:09","pubTimestamp":1790842140,"startTime":"0","endTime":"0","summary":"0809 GMT - Sanofi's expanded alliance with Regeneron Pharmaceuticals represents the French drugmaker's first step toward addressing its long-term outlook and should be seen as a clear sign of progress under new CEO Belen Garijo, Jefferies analysts write in a research note. \"While the assets are early-stage, the expansion should be viewed positively, as it signals the new CEO's proactive focus on the most important yet addressable uncertainties investors face, as well as the speed of progress,\" the analysts say. Potential acquisitions and a settlement to delay the arrival of copycat versions of the alliance's blockbuster drug Dupixent are other key steps Sanofi needs to take to address the sales hole left by that medicine's patent expiration between 2031 and 2032, the analysts add. Sanofi shares rise 0.6%.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1917777945.USD","LU2237438978.USD","LU2362540622.SGD","BK4588","SNY","LU0109394709.USD","LU0289739699.SGD","LU0320765992.SGD","LU0114720955.EUR","LU2362541273.HKD","TBXU","LU2023250504.SGD","LU0823416689.USD","LU1974910355.USD","SNYNF","LU0889565916.HKD","LU0058720904.USD","REGN","LU2362541513.USD","LU0053666078.USD","LU2324357040.USD","BK4139","LU2106854487.HKD","IE00BFXG1179.USD","BBH","LU2468319806.SGD","LU0882574055.USD","BK4007","BK4585","LU2089984988.USD","IBBQ","IBB","LU0823434583.USD","LU0823434740.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672073056","title":"Sanofi to Get Pipeline Boost from Expanded Regeneron Alliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2672073056","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672073056?lang=en_us&edition=fundamental","pubTime":"2026-10-01 15:10","pubTimestamp":1790838600,"startTime":"0","endTime":"0","summary":"0709 GMT - Sanofi's deal to expand its alliance with U.S. peer Regeneron Pharmaceutical provides a boost to the French company's early-stage drug pipeline, J.P. Morgan analysts write in a research note. The conclusion of the negotiations with Regeneron is positive for Sanofi, the analysts say. Sanofi will pay Regeneron $1 billion upfront, and up to $7 billion subject to certain targets to get access to four new drug candidates invented by its partner. Now that an agreement with Regeneron has been reached, Sanofi investors are likely to switch their focus to the company's moves to strengthen its business through dealmaking, the analysts say. Sanofi shares rise 2%.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","IBBQ","BK4585","BK4007","LU2023250504.SGD","LU0053666078.USD","LU0823434740.USD","LU2468319806.SGD","SNY","BK4588","LU2237438978.USD","BK4139","LU2106854487.HKD","LU2362540622.SGD","LU0109394709.USD","LU2324357040.USD","IBB","BBH","LU0889565916.HKD","TBXU","LU0058720904.USD","LU0882574055.USD","IE00BFXG1179.USD","LU0289739699.SGD","LU0823434583.USD","LU0320765992.SGD","LU2362541513.USD","LU1974910355.USD","LU2362541273.HKD","REGN","SNYNF","LU1917777945.USD","LU0114720955.EUR","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672734089","title":"Sanofi, Regeneron Expand Tie-up with $8 Billion Drug-Development Deal, Settle Legal Dispute","url":"https://stock-news.laohu8.com/highlight/detail?id=2672734089","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672734089?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:40","pubTimestamp":1790833252,"startTime":"0","endTime":"0","summary":"UPDATE 4-Sanofi, Regeneron expand tie-up with $8 billion drug-development deal, settle legal disputeOct 1 (Reuters)-SanofiSASY.PAand RegeneronREGN.Osaid on Thursday they will develop four new drugs to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nL6N45N09P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU2237438978.USD","LU0823416689.USD","LU1974910355.USD","BBH","LU2468319806.SGD","LU2106854487.HKD","LU2023250504.SGD","LU0823434583.USD","BK4585","BK4588","REGN","IBB","LU2362541273.HKD","LU0289739699.SGD","LU0882574055.USD","LU0823434740.USD","LU1917777945.USD","IBBQ","LU0058720904.USD","LU0320765992.SGD","LU2324357040.USD","TBXU","BK4139","LU0114720955.EUR","LU2362541513.USD","LU2362540622.SGD","LU0053666078.USD","LU2089984988.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672734581","title":"Regeneron, Sanofi Expand Antibody Alliance with USD 1 Billion Upfront Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2672734581","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672734581?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:01","pubTimestamp":1790830918,"startTime":"0","endTime":"0","summary":"Regeneron, Sanofi expand antibody alliance with USD 1 billion upfront paymentRegeneron expanded its immunology alliance with Sanofi to co-develop and co-commercialize four next-generation, long-acting","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL5hDHkz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU0058720904.USD","LU0320765992.SGD","IE00BN0W2W23.USD","LU0823434583.USD","IE00B3QW5Z07.USD","LU0823434740.USD","BCDF","LU1974910355.USD","LU2362541513.USD","LU0889565916.HKD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","LU0114720955.EUR","LU2468319806.SGD","BK4585","LU2362541273.HKD","IE00B64PRP62.GBP","LU0109394709.USD","LU0289739699.SGD","LU0314104364.USD","TBXU","LU1917777945.USD","LU2362540622.SGD","SG9999014005.SGD","LU2324357040.USD","SG9999014039.USD","REGN","SG9999014013.SGD","BBH","LU2095319765.USD","IBB","IE00BQXX3D17.EUR","LU2210149790.SGD","BK4112","IE00BQXX3C00.GBP","LU0053666078.USD","LU0823416689.USD","SG9999014021.USD","BK4139","LU2106854487.HKD","LU2210150020.SGD","IBBQ","IE00BQXX3F31.USD","BK4588","LU2237438978.USD","LU2089984988.USD","IE00BKPKM429.USD","LU0882574055.USD","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672533734","title":"Sanofi, Regeneron Expand Antibody Alliance in Long-Acting Immunology Programs for USD 1 Billion Upfront","url":"https://stock-news.laohu8.com/highlight/detail?id=2672533734","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672533734?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:01","pubTimestamp":1790830877,"startTime":"0","endTime":"0","summary":"Sanofi, Regeneron expand antibody alliance in long-acting immunology programs for USD 1 billion upfrontSanofi expanded its global antibody alliance with Regeneron to add four next-generation, long-act","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDLbTWmXB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237438978.USD","LU0053666078.USD","IE00BQXX3F31.USD","LU0114720955.EUR","IE00BN0W2T93.GBP","REGN","BK4588","SG9999014013.SGD","IE00BKPKM429.USD","LU0314104364.USD","LU1974910355.USD","BCDF","LU2023250504.SGD","LU0823434583.USD","BK4585","LU2210150020.SGD","LU2324357040.USD","LU0882574055.USD","LU2210149790.SGD","IBBQ","BK4112","LU2095319765.USD","LU0823416689.USD","NDAQ","LU2362541273.HKD","BBH","LU0109394709.USD","LU0889565916.HKD","SG9999014039.USD","LU2362540622.SGD","TBXU","LU0289739699.SGD","IE00B3QW5Z07.USD","LU0320765992.SGD","LU2089984988.USD","IE00BQXX3C00.GBP","IE00BQXX3D17.EUR","BK4139","LU2362541513.USD","LU0058720904.USD","IE00B64PRP62.GBP","SG9999014005.SGD","LU2106854487.HKD","LU2468319806.SGD","IE00BN0W2V16.EUR","LU0823434740.USD","SG9999014021.USD","IE00BGHQF748.EUR","LU1917777945.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672734593","title":"Sanofi - Companies to Equally Share Development and Commercialization Costs, as Well as Any Future Profits","url":"https://stock-news.laohu8.com/highlight/detail?id=2672734593","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672734593?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:00","pubTimestamp":1790830810,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N05O:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1974910355.USD","LU2324357040.USD","BK4588","BK4139","LU2362541513.USD","LU0882574055.USD","LU0109394709.USD","LU0823416689.USD","BK4585","LU2089984988.USD","TBXU","LU0823434583.USD","LU0320765992.SGD","LU0889565916.HKD","LU2362541273.HKD","IBB","LU2468319806.SGD","BBH","LU0053666078.USD","LU0823434740.USD","LU0289739699.SGD","LU2023250504.SGD","LU1917777945.USD","LU2362540622.SGD","LU2237438978.USD","LU0058720904.USD","LU2106854487.HKD","IBBQ","LU0114720955.EUR","REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672573435","title":"Sanofi - and Regeneron Settle Prior Collaboration-Related Litigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2672573435","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672573435?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:00","pubTimestamp":1790830810,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N05O:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBB","LU2023250504.SGD","LU0889565916.HKD","LU2468319806.SGD","BK4139","LU0058720904.USD","LU0823434583.USD","REGN","LU0882574055.USD","BBH","LU0289739699.SGD","LU1917777945.USD","LU0823434740.USD","LU2324357040.USD","LU2237438978.USD","TBXU","LU2362540622.SGD","LU0823416689.USD","BK4588","LU0053666078.USD","LU0109394709.USD","BK4585","LU2106854487.HKD","LU0114720955.EUR","LU2362541513.USD","LU2089984988.USD","LU2362541273.HKD","LU0320765992.SGD","LU1974910355.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672343697","title":"Sanofi - Regeneron May Include Sanofi's Lunsekimig Therapy After Phase 3 Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2672343697","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672343697?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:00","pubTimestamp":1790830810,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N05O:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1974910355.USD","LU2324357040.USD","BK4588","BK4139","LU2362541513.USD","LU0882574055.USD","LU0109394709.USD","LU0823416689.USD","BK4585","LU2089984988.USD","TBXU","LU0823434583.USD","LU0320765992.SGD","LU0889565916.HKD","LU2362541273.HKD","IBB","LU2468319806.SGD","BBH","LU0053666078.USD","LU0823434740.USD","LU0289739699.SGD","LU2023250504.SGD","LU1917777945.USD","LU2362540622.SGD","LU2237438978.USD","LU0058720904.USD","LU2106854487.HKD","IBBQ","LU0114720955.EUR","REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672734350","title":"Sanofi - Regeneron to Receive $1 Bln Upfront with Potential for up to an Additional $7 Bln in Future Milestone Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2672734350","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672734350?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:00","pubTimestamp":1790830808,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45M1B3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2237438978.USD","BK4139","LU0289739699.SGD","LU0109394709.USD","BBH","LU1974910355.USD","LU1917777945.USD","LU0823434740.USD","LU2106854487.HKD","IBBQ","LU2089984988.USD","LU0823434583.USD","LU0889565916.HKD","REGN","LU0114720955.EUR","LU2324357040.USD","LU2362541513.USD","BK4588","LU2468319806.SGD","LU0882574055.USD","TBXU","LU0320765992.SGD","IBB","LU2023250504.SGD","LU2362541273.HKD","BK4585","LU0823416689.USD","LU2362540622.SGD","LU0053666078.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672983731","title":"Arovella Nears First Patient Dosing in Pivotal ALA-101 Cell Therapy Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2672983731","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672983731?lang=en_us&edition=fundamental","pubTime":"2026-10-01 12:18","pubTimestamp":1790828280,"startTime":"0","endTime":"0","summary":"Arovella Therapeutics Limited ( ($AU:ALA) ) has provided an announcement. Arovella Therapeutics is advancing an iNKT cell therapy platform aimed at...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arovella-nears-first-patient-dosing-in-pivotal-ala-101-cell-therapy-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arovella-nears-first-patient-dosing-in-pivotal-ala-101-cell-therapy-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNCR","GNOM","BK4585","BK4588","IBBQ","IBB","LFSC","LABX","FBT","ALA","TBXU","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672273391","title":"The Next Frontier for Obesity Drugs Isn't How Much Weight You Lose, but What Kind","url":"https://stock-news.laohu8.com/highlight/detail?id=2672273391","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672273391?lang=en_us&edition=fundamental","pubTime":"2026-10-01 08:00","pubTimestamp":1790812800,"startTime":"0","endTime":"0","summary":"For as long as drugmakers have been testing weight-loss drugs, the question has been: How much weight do people lose?Now it is changing to: What kind of weight are they losing?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014906.USD","IE0001KFT4U8.USD","LU0471298694.HKD","LU2023250330.USD","LU2456880835.USD","IE00BK4W5L77.USD","ELIL","LU2471134523.USD","MEDX","SGXZ81514606.USD","LU2168564222.USD","IXJ","LU0109391861.USD","LU1988902786.USD","HRTS","LU2471134952.CNY","LU2462157665.USD","LU2552382215.SGD","LU0133085943.USD","LU2271345857.HKD","TMED","LU1023059063.AUD","LU2468319806.SGD","BK4534","FHLC","LU1093756325.SGD","LU1280957306.USD","IYH","LU1868837136.USD","LU2362541273.HKD","PPH","NVOX","IBBQ","LU2023251221.USD","LU0238689110.USD","LU0466842654.USD","LU2491050071.SGD","LU0456855351.SGD","LU0114720955.EUR","LU1691799644.USD","IE00BFSS8Q28.SGD","LU1868836757.USD","LU2168563687.JPY","LU2552382058.USD","IE00BK4W5M84.HKD","LU0096364046.USD","SG9999015945.SGD","IE00B1BXHZ80.USD","LU1979441026.SGD","LLII","OZEM","SG9999015986.USD","LU0787776722.HKD","LU2461242641.AUD","LU2108987350.USD","BK4139","LU0006306889.USD","LU0345770308.USD","VHT","BK4585","LU2362541513.USD","IE00B775H168.HKD","LU1868836914.USD","LU1720051108.HKD","LU0820561909.HKD","LU0354030511.USD","IE00BJJMRX11.SGD","NVO","LU0174119429.USD","CURE","LU2112291526.USD","BBH","BK4599","LU1267930730.SGD","SG9999013999.USD","LU2237443978.SGD","LU0889565916.HKD","LU0106261372.USD","LU0210536198.USD","LU1623119135.USD","SGXZ57979304.SGD","LU0640476718.USD","LU1868836591.USD","LU2462591350.SGD","LU2896262040.SGD","RXL","LU2089283258.USD","BK4581","LU0353189763.USD","SG9999018865.SGD","LU0345770993.USD","LU0823434583.USD","LU1983299246.USD","LU1629891620.HKD","LU0158827948.USD","LU1974910355.USD","LU1064131342.USD","LU1145028129.USD","NVOC","LU0320765992.SGD","LU2361044949.HKD","IE00B7KXQ091.USD","LU2106854487.HKD","LU0672654240.SGD","LU2063271972.USD","IE00BZ1G4Q59.USD","LU1551013425.SGD","LU2756315318.SGD","LU0689472784.USD","LU1291159041.SGD","LU2602419157.SGD","IE00BJJMRZ35.SGD","ILDR","JDOC","SG9999001176.USD","LU2264538146.SGD","LU0823416689.USD","SG9999017495.SGD","IE0002141913.USD","SGXZ31699556.SGD","LU2168564149.EUR","IE00BJJMRY28.SGD","LU0820562030.AUD","SG9999018857.SGD","IE00B4JS1V06.HKD","IHE","LU2168564495.EUR","LU2237443549.SGD","LU2471134879.HKD","LLYX","TRUH","LU1035775433.USD","LU2491049909.HKD","LU1232071149.USD","IBB","IE00BJT1NW94.SGD","LU2213496289.HKD","LU0053666078.USD","LU1804176565.USD","REGN","LU2491050154.USD","IE0005OL40V9.USD","IE00BN29S564.USD","LU2552382132.HKD","SGXZ51526630.SGD","GB00BDT5M118.USD","LU2360106947.USD","LU0122379950.USD","LU2746668461.USD","LU2361045086.USD","LU0432979614.USD","LU1551013342.USD","NVOH","LU0203202063.USD","LU0256863902.USD","LU0320765059.SGD","LU0061475181.USD","SG9999015952.SGD","LU2211815571.USD","LU2362540622.SGD","TBXU","SG9999014898.SGD","MHIP","IE00BKPKM429.USD","LU2750360641.GBP","LU1366192091.USD","LU2236285917.USD","IE00B1XK9C88.USD","LU0882574139.USD","LU1093756168.USD","LU0203201768.USD","LU0964807845.USD","LU2087625088.SGD","LU2237438978.USD","IE00B2B36J28.USD","AGNG","GDOC","LU1814569148.SGD","IE0004445015.USD","LU0385154629.USD","LU2237443622.USD","LU2237443465.HKD","LU0094547139.USD","LU1548497426.USD","LU0316494557.USD","WDNA","LU1712237335.SGD","LU2746668974.SGD","CANC","IE00BFTCPJ56.SGD","LU0786609619.USD","SG9999001176.SGD","LU0820561818.USD","LU1061106388.HKD","LU0417517546.SGD","LU0256863811.USD","BK4588","LU1069344957.HKD","LLYZ","LU2028103732.USD","SG9999015978.USD","LU1868837300.USD","LU2324357040.USD","LU2471134796.USD","IE00BKDWB100.SGD","LU0353189680.USD","IE0009355771.USD","IE00BJLML261.HKD","IE00BKVL7J92.USD","ELIS","LU0109394709.USD","LU2111349929.HKD","SG9999014914.USD","LU0079474960.USD","LU0708995401.HKD","MEDI","IE0004445239.USD","LU0154236417.USD","LU0158827781.USD","LU2756315664.SGD","PJP","BK4516","LU1917777945.USD","LU0058720904.USD","LU0225283273.USD","LU0323591593.USD","LU0683600562.USD","LU0289739699.SGD","LLY","LU0823434740.USD","XLV","LU0198837287.USD","LU2237443895.HKD","LU2237443382.USD","IE00BWXC8680.SGD","IE00BFSS7M15.SGD","LU1057294990.SGD","LU1127390331.HKD","BK4007","LU2361044865.SGD","LU0097036916.USD","LU1720051017.SGD","LU2023250504.SGD","LU0234572021.USD","LU2750360997.AUD","SG9999014880.SGD","THNR","LU1323610961.USD","LU0354030438.USD","LU2168564065.EUR","IE00B4R5TH58.HKD","BK4532","LU0471298777.SGD","LU1989771016.USD","LU2265009873.SGD","LU2357305700.SGD","LU0943347566.SGD","LU0882574055.USD","LU2089984988.USD","LU0266013472.USD","LU2417539215.USD","SGXZ99366536.SGD","BK4533","LU2089284900.SGD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672809747","title":"Regeneron Drug Halves Muscle Loss in Combination with Novo's Semaglutide in Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2672809747","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672809747?lang=en_us&edition=fundamental","pubTime":"2026-10-01 06:01","pubTimestamp":1790805660,"startTime":"0","endTime":"0","summary":"Regeneron drug halves muscle loss in combination with Novo's semaglutide in trialSept 30 (Reuters)-An experimental weight-loss drug being developed by RegeneronREGN.Oused in combination with Novo Nord","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL4N45L14A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","IBB","LU0053666078.USD","LU1917777945.USD","LU0114720955.EUR","LU2023250504.SGD","LU0823434583.USD","BK4588","LU2362541273.HKD","BK4139","LU0320765992.SGD","LU0109394709.USD","LU2468319806.SGD","LU2362540622.SGD","IBBQ","LU1974910355.USD","LU0823416689.USD","TBXU","LU0889565916.HKD","LU2106854487.HKD","BK4585","LU2237438978.USD","LU2362541513.USD","LU0289739699.SGD","LU2324357040.USD","BBH","REGN","LU0882574055.USD","LU2089984988.USD","LU0823434740.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672774782","title":"Gilead Sciences Inc. Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672774782","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672774782?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:35","pubTimestamp":1790800500,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slipped 1.47% to $149.05 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,651.54 and Dow Jones Industrial Average  falling 0.86% to 50,906.05.This was the stock's second consecutive day of losses.Gilead Sciences Inc. closed 5.24% short of its 52-week high of $157.29, which the company achieved on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson  fell 1.06% to $264.74, Pfizer Inc.  fell 0.70% to $28.52, and Abbott Laboratories  fell 2.10% to $98.83.Data source: Dow Jones Market Data, FactSet. Data compiled September 30, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455863.HKD","LU2089984988.USD","LU0859254822.USD","LU0114720955.EUR","LU1839511570.USD","SG9999015952.SGD","LU0882574055.USD","LU0122379950.USD","BK4139","LU1037948541.HKD","IE00B19Z3581.USD","LU0320765992.SGD","LU1674673428.USD","BIB","IE00B7SZLL34.SGD","LU0861579265.USD","LU1585245621.USD","LU2468319806.SGD","IBB","LU2324357040.USD","BK4588","LU0058720904.USD","LU0289739699.SGD","LU1023059063.AUD","LU1674673691.USD","LU1061106388.HKD","LU1571399168.USD","LU1066053197.SGD","GILD","BK4566","IE0002270589.USD","LU1057294990.SGD","LU2357627491.SGD","BBH","BK4550","BK4578","LU1430594728.SGD","LU0823416689.USD","LU2112291526.USD","BK4585","LU1934455194.USD","LU1037948897.HKD","BK4583","MEDI","LU1778281490.HKD","SG9999015945.SGD","SG9999015986.USD","LU0109394709.USD","LU0889565916.HKD","IE00BSNM7G36.USD","SG9999015978.USD","LU0965509010.AUD","TBXU","IE00B3T34201.USD","LU0965509101.SGD","LU1934455277.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0965508806.USD","BK4568","LU1066051498.USD","IBBQ","TMED","LU2087621335.USD","BK4532","LU0234570918.USD","BMED","IE00B19Z3B42.SGD","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672278203","title":"Moderna Inc. Stock Sheds 5.4%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2672278203","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672278203?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:33","pubTimestamp":1790800380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slipped 5.4% to $192.57 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 26,861.06 and the Dow Jones Industrial Average falling 0.9% to 50,906.05.Moderna Inc. closed 7.8% short of its 52-week high of $208.90, which the company reached on September 29th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.1% to $264.74, Pfizer Inc. fell 0.7% to $28.52, and Gilead Sciences Inc. fell 1.47% to $149.05.Trading volume totaled 20.1 million, compared to the 50-day average of 19.4 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","IBB","WDNA","LU0109394709.USD","LU1778281490.HKD","BK4566","LU1934455863.HKD","LU0320765992.SGD","LU1934455194.USD","SG9999015952.SGD","BMED","LU1674673691.USD","IE00BSNM7G36.USD","LU1430594728.SGD","TBXU","LU1934455277.USD","MRNY","BK4550","IE00B19Z3B42.SGD","LU2357627491.SGD","MRNA","BK4534","IE0002270589.USD","BK4585","BK4139","LU1057294990.SGD","LU1066053197.SGD","BK4532","LGHT","LU1066051498.USD","BIB","LU2087621335.USD","IE00BZ1G4Q59.USD","MRNX","IDNA","TMED","LU0058720904.USD","LU1023059063.AUD","LU1037948897.HKD","GNOM","SG9999015945.SGD","SG9999015986.USD","BBH","GILD","MEDI","LU0289739699.SGD","BK4583","LU2089984988.USD","IBBQ","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672078261","title":"Regeneron Links 2026 CEO, CSO PSU Awards to FDA Filings, Approvals and New-Product Revenue Targets Through 2035","url":"https://stock-news.laohu8.com/highlight/detail?id=2672078261","media":"Reuters","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672078261?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:14","pubTimestamp":1790799285,"startTime":"0","endTime":"0","summary":"Regeneron links 2026 CEO, CSO PSU awards to FDA filings, approvals and new-product revenue targets through 2035Regeneron set 2026 performance stock units for its CEO and CSO with a 10-year performance","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL6RTPN0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","IBBQ","BK4585","LU2023250504.SGD","LU0053666078.USD","LU0823434740.USD","LU2468319806.SGD","BK4588","LU2237438978.USD","BK4139","LU2106854487.HKD","LU2362540622.SGD","LU0109394709.USD","LU2324357040.USD","IBB","BBH","LU0889565916.HKD","TBXU","LU0058720904.USD","LU0882574055.USD","LU0289739699.SGD","LU0823434583.USD","LU0320765992.SGD","LU2362541513.USD","LU1974910355.USD","LU2362541273.HKD","REGN","LU1917777945.USD","LU0114720955.EUR","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672784566","title":"Gilead put volume heavy and directionally bearish","url":"https://stock-news.laohu8.com/highlight/detail?id=2672784566","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672784566?lang=en_us&edition=fundamental","pubTime":"2026-10-01 03:15","pubTimestamp":1790795714,"startTime":"0","endTime":"0","summary":"Bearish flow noted in Gilead (GILD) with 6,354 puts trading, or 4x expected. Most active are Nov-26 140 puts and 10/9 weekly 146 puts, with total v...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilead-put-volume-heavy-and-directionally-bearish-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilead-put-volume-heavy-and-directionally-bearish-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","LU0234570918.USD","LU1778281490.HKD","BK4532","BK4568","LU1057294990.SGD","LU1839511570.USD","LU2087621335.USD","LU0889565916.HKD","LU1585245621.USD","BMED","LU0965509010.AUD","LU0965509283.SGD","BK4583","LU2468319806.SGD","LU0058720904.USD","SG9999015945.SGD","TMED","LU1066051498.USD","IE00BSNM7G36.USD","BK4588","BBH","SG9999015986.USD","IBB","IE00BKVL7J92.USD","BIB","LU2112291526.USD","IBBQ","LU0289739699.SGD","LU1037948897.HKD","LU1934455863.HKD","LU0823416689.USD","TBXU","LU0882574055.USD","LU2324357040.USD","MEDI","BK4585","LU1430594728.SGD","LU2357627491.SGD","LU0859254822.USD","BK4578","SG9999015952.SGD","SG9999015978.USD","IE00B3T34201.USD","BK4550","GILD","LU1061106388.HKD","IE00B19Z3B42.SGD","LU0114720955.EUR","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672174789","title":"Exchange-Traded Funds Higher, US Equities Mixed After Midday","url":"https://stock-news.laohu8.com/highlight/detail?id=2672174789","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672174789?lang=en_us&edition=fundamental","pubTime":"2026-10-01 01:16","pubTimestamp":1790788573,"startTime":"0","endTime":"0","summary":"Broad Market IndicatorsBroad-market exchange-traded funds IWM and IVV rose. Actively traded Invesco QQQ Trust (QQQ) added 0.7%.US equity indexes traded mixed as August spending growth and a soft infla","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CBTJ","BTC.USD.CC","AAAU","VHT","ETCO","QDEC","UNG","XLPU","RETL","SOXS","KGLD","SQQQ","BRRR","GLDY","GLDM","IYE","DGP","XLI","BPI","IBIT","AGQ","BK4547","NJUL","USO","GLL","CBOO","CBTA","IGLD","SOXL","XLP","DFII","ETHT","BTF","FGDL","FAS","MAXI","DULL","EETH","ARKB","BTRN","BFJL","BK4593","BK4570","SCO","IGM","BK4550","SLV","BK4534","XAGUSD.FOREX","BK4588","BETH","NOCT","GBTC","GLD","EZBC","PSQ","ETQ","FAZ","BITB","CBXA","QQQ","XSD","MNRS","YBTC","QLD","IYJ","OUNZ","BTCZ","BK4561","BTCI","BITY","ETH.USD.CC","ETHD","NAPR","BCCC","BTCL","NJAN","CBOA","BITO","ETH","TQQQ","YGLD","SHNY","HODL","QID","FBTC","XLY","BITX","BK4581","SETH","BITI","IYW","QMAR","CBTO","BAGY","XLV","IAUM","RTH","SGOL","SOXX","TQQY","BAR","VIS","QQQM","CBTY","BGLD","BTCO","NDX","XLE","CBXY","BITU","IBB","UCO","XLF","CBOJ","QBF","USG","XBTY","DEFI","XRT","IAUI","VDC","BTCW","ESK","DZZ","SIVR","TECL","TETH","CBXJ","XLPD","XAUUSD.FOREX","ZSL","IAU","XBI","DGZ","BTCC","CBOY","UGL","QQQX","IYH","LABU","BFAP","BETE","XLK","SBIT","CBXO","BTC","BK4585","GPIQ","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672789918","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2672789918","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672789918?lang=en_us&edition=fundamental","pubTime":"2026-10-01 01:08","pubTimestamp":1790788105,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Wednesday afternoon, with the NYSE Healthcare Index down 0.4% and the State Street Health Care Select Sector SPDR ETF  shedding 0.3%.The iShares Biotechnology ETF  rose 0.4%.In corporate news, Eli Lilly  on Wednesday reported positive results from a phase 2b trial of its investigational combination of eloralintide and tirzepatide in 367 obese or overweight adults with type 2 diabetes. All combinations of EloraTZP met the primary and secondary endpoints at 48 weeks, delivering \"substantial\" weight loss and A1C reduction, the company said. Lilly shares were up 0.2%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BK4W5M84.HKD","IBB","LU1064131342.USD","LU1057294990.SGD","LU0345770993.USD","LABU","LU2456880835.USD","LU0943347566.SGD","LU0354030438.USD","LU0820561909.HKD","LU0234572021.USD","SG9999018865.SGD","GDOC","LU0114720955.EUR","LU0964807845.USD","LU2023250330.USD","LU2746668974.SGD","LU2236285917.USD","LU2361045086.USD","IE00B2B36J28.USD","LU2468319806.SGD","LU0094547139.USD","BK4007","LU0456855351.SGD","SGXZ51526630.SGD","ILDR","LU1868837300.USD","LU0672654240.SGD","LU0128526141.USD","LLYZ","LU0466842654.USD","LU2213496289.HKD","LU2361044949.HKD","LU0320765992.SGD","LU2746668461.USD","GB00BDT5M118.USD","LU1093756168.USD","SG9999015952.SGD","BK4581","LU0029874061.USD","SG9999018857.SGD","WDNA","LU2471134523.USD","LLY","LU2552382132.HKD","LU1035775433.USD","BK4534","IXJ","LU2361044865.SGD","SG9999014914.USD","LU1061106388.HKD","OZEM","LU2552382215.SGD","LU0708995401.HKD","LU1974910355.USD","IE0005OL40V9.USD","BK4533","LU0266013472.USD","LU0882574055.USD","LU2750360641.GBP","HRTS","LU2168564065.EUR","LU1989771016.USD","SG9999014880.SGD","CURE","LU1868836591.USD","LU1548497426.USD","IE00BFSS8Q28.SGD","LU0096364046.USD","LU0198837287.USD","IE00BKPKM429.USD","LU0385154629.USD","LU2063271972.USD","LU0689472784.USD","LU2089284900.SGD","IE00BN29S564.USD","XLV","LU1291159041.SGD","IE00BFSS7M15.SGD","LU0256863902.USD","AGNG","HCSG","IE0001KFT4U8.USD","LU2168563687.JPY","LU2756315318.SGD","IE00B1XK9C88.USD","SG9999001176.SGD","IE00BK4W5L77.USD","ELIS","IE0004445239.USD","LU0061475181.USD","BK4588","LU1868836757.USD","LU2023251221.USD","SGXZ81514606.USD","LU0058720904.USD","TMED","LU0353189680.USD","LU2271345857.HKD","LU0225283273.USD","LU0320765059.SGD","SG9999017495.SGD","LU0432979614.USD","LU2461242641.AUD","LU2896262040.SGD","BK4599","LU1551013342.USD","LU1280957306.USD","LU0787776722.HKD","LU0353189763.USD","LU0106261372.USD","LU1629891620.HKD","LU2237438978.USD","IE00BWXC8680.SGD","LU0323591593.USD","IE00B7KXQ091.USD","LU1814569148.SGD","LU1712237335.SGD","SG9999014906.USD","IE00BJJMRY28.SGD","IYH","LU0471298694.HKD","LU2750360997.AUD","LU0823434740.USD","LU0640476718.USD","LU1127390331.HKD","LU2089283258.USD","RXL","SGXZ57979304.SGD","LU0316494557.USD","LU2168564222.USD","LU2237443622.USD","XBI","SGXZ31699556.SGD","LU2491050071.SGD","TRUH","LU0109394709.USD","LU2264538146.SGD","LU0210536198.USD","LU0354030511.USD","LU1868836914.USD","LU2089984988.USD","LU2357305700.SGD","LU2462157665.USD","CANC","LU0882574139.USD","LU1979441026.SGD","LU2211815571.USD","IE00B4JS1V06.HKD","IE0004445015.USD","LU1093756325.SGD","LLYX","IE00B775H168.HKD","IE00BKDWB100.SGD","SGXZ99366536.SGD","ELIL","LU1023059063.AUD","LU1983299246.USD","LU1623119135.USD","SG9999001176.USD","SG9999014898.SGD","LU1366192091.USD","LU0889565916.HKD","LU0158827781.USD","LU0174119429.USD","FTXH","LU1069344957.HKD","LU2112291526.USD","MEDI","SG9999013999.USD","LU2756315664.SGD","LU2111349929.HKD","LU0203201768.USD","BK4585","LU0256863811.USD","LU1232071149.USD","LU2491049909.HKD","LU0097036916.USD","LU2471134796.USD","LU0823434583.USD","PPH","LU0109391861.USD","IE00BJLML261.HKD","LU0345770308.USD","LU2237443465.HKD","LU2237443895.HKD","LU0820561818.USD","LU2237443978.SGD","LU1323610961.USD","SG9999015978.USD","IE0002141913.USD","LU2106854487.HKD","LU0823416689.USD","IHE","IE00BJJMRZ35.SGD","LU0471298777.SGD","LU2087625088.SGD","LU2168564495.EUR","MEDX","LU2028103732.USD","LU0203202063.USD","LU0683600562.USD","LLII","LU0158827948.USD","LU2491050154.USD","LU2602419157.SGD","LU1917777945.USD","LU2417539215.USD","LU1720051017.SGD","LU0820562030.AUD","LU1267930730.SGD","JDOC","IE00BJT1NW94.SGD","LU2237443382.USD","LU2265009873.SGD","THNR","LU2168564149.EUR","LU2552382058.USD","LU0122379950.USD","LU1145028129.USD","VHT","LU2237443549.SGD","PJP","LU0133085943.USD","LU0238689110.USD","LU1691799644.USD","IE00BJJMRX11.SGD","LU0417517546.SGD","LU1988902786.USD","LU0289739699.SGD","LU2324357040.USD","SG9999015945.SGD","LU1551013425.SGD","IE0009355771.USD","LU2023250504.SGD","LU2108987350.USD","LU2471134879.HKD","IE00B1BXHZ80.USD","FHLC","IE00B4R5TH58.HKD","BK4137","LU0079474960.USD","LU1804176565.USD","LU1868837136.USD","LU0006306889.USD","LU2462591350.SGD","MHIP","SG9999015986.USD","LU1720051108.HKD","LU2471134952.CNY","BK4516","IE00BFTCPJ56.SGD","LU2360106947.USD","LU0786609619.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672786096","title":"Regeneron’s ALN-F1202 Safety Trial Marks a Quiet but Important Pipeline Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2672786096","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672786096?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:30","pubTimestamp":1790785810,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals, Inc. (REGN) has completed a Phase...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regenerons-aln-f1202-safety-trial-marks-a-quiet-but-important-pipeline-milestone?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regenerons-aln-f1202-safety-trial-marks-a-quiet-but-important-pipeline-milestone?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823416689.USD","IBB","LU2362540622.SGD","LU0109394709.USD","LU0053666078.USD","LU0320765992.SGD","REGN","LU2362541513.USD","ALN","LU1917777945.USD","LU2237438978.USD","TBXU","LU0889565916.HKD","LU2023250504.SGD","LU2468319806.SGD","BK4585","LU2106854487.HKD","BK4139","LU0882574055.USD","LU0823434740.USD","LU2324357040.USD","LU1974910355.USD","LU0058720904.USD","LU0114720955.EUR","BBH","BK4588","LU0823434583.USD","LU0289739699.SGD","LU2089984988.USD","IBBQ","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671778532","title":"European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2671778532","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671778532?lang=en_us&edition=fundamental","pubTime":"2026-09-30 23:19","pubTimestamp":1790781554,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending lower late Wednesday morning, declining 0.43% to 1,911.17 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and biopharmaceutical company DBV Technologies , which rose 5.2% and 3.4% respectively. They were followed by biopharmaceutical company Cellectis  and internet browser company Opera , which were up 2.4% and 1.3% respectively.The decliners from continental Europe were led by accommodations booking site trivago  and biopharmaceutical company argenx , which dropped 2.2% and 1.7% respectively. They were followed by healthcare tech company Royal Philips  and lender Banco Santander , which lost 1.2% and 1% respectively.The gainers from the UK were led by biopharmaceutical company NuCana  and software firm Endava , which advanced 7.9% and 4.9% respectively. They were followed by biotech firm Autolus Therapeutics  and biopharmace","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2324357040.USD","LU0648005311.SGD","GSK","IE0002141913.USD","LU0109394709.USD","EPV","PUK","MREO","BK4521","IE00B2B36J28.USD","LU1983260115.SGD","SQNS","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","DAVA","ARGX","BK7142","IEUR","LU0823416689.USD","BK4588","NCNA","AFG","GSIB","SAN.AU","BK4134","BK4162","OPRA","GSK.UK","TBXU","TRIB","LFGY","PHG","TRVG","WPP","BK4082","CLLS","IE00BFTCPJ56.SGD","FMED","WPP.AU","AUTL","SAN","DAVA.AU","DBVT","BK4023","IBB","GSKH","LU0390134368.USD","BK4117","LU0084288595.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}